How Ro introduces the Wegovy pill with a simple motion graphic | Fluid
Esc

How Ro introduces the Wegovy pill with a simple motion graphic

A 19-second motion graphic with no voiceover, introducing the Wegovy pill with large pills on a blue background. Glass cards claim an average weight loss figure from a study and the lowest-cost FDA-approved GLP-1. It ends on See if you qualify and full safety information, and sends people to Ro's weight-loss quiz.

Ro
71 creatives lead here1 / 71
Ro · Serena-led weight-loss quiz

Public page captured October 22, 2026. Promotional sheets and temporary interface overlays were dismissed or removed in the static reference. No personal or medical information was entered. Captured entry screens do not reproduce the complete consultation.

Ro: full page screenshot

See if you qualify

Visual reference: Meet Wegovy pill · annual-results still. The main campaign sends price, medication-launch, creator and celebrity ads to one Serena-led entrance. A treatment-format question sits in the hero; choosing Learn about both reveals a weight-goal question without leaving the page. Compare the creative with the destination and explore the other ads sharing this route.

Brand
Ro
Observed offer
Online GLP-1 assessment; medication and membership terms apply
Creative angle
Creator stories
Page type
Quiz entry
Ad format
Video · 0:19
Listed start date
Oct 20, 2026
Captured
Oct 22, 2026
Library ID
1428801096126207
Destination
ro.co

Selected for its design and offer structure. Ad performance isn’t available in this collection.

What this ad does well

The headline, Meet the Wegovy pill, works like a launch announcement, and for someone who's been waiting for a pill instead of an injection that's news worth stopping for. The two claim cards are short and specific, with the study details and a your results may vary line printed on the same frame. The giant pills make the product the whole scene, so nobody has to guess what's being announced. Ro started running it on Meta on October 20, 2026.

What's missing

There's no person in it and no reason to choose Ro over anywhere else that offers the same pill, apart from the lowest-cost line, which doesn't come with a price. The ad assumes the viewer already wants a pill. If you make a launch ad like this, add the price next to the cost claim and pair the motion graphic with a creator version that explains why a pill matters to them (no needles, easier routine).

Beat by beat

  1. 0-4s
    Meet the Wegovy pill appears in large white type with a semaglutide tag, alongside the safety notice at the top.

    It frames the ad as a launch, which gives people a reason to stop.

  2. 4-10s
    Glass cards claim an average weight loss figure in a year and the lowest-cost FDA-approved GLP-1, with study details in fine print.

    Two short claims give the viewer the main reasons to care, with the conditions on the same frame.

  3. 10-14s
    An FDA approved badge and See if you qualify appear over the large pills.

    It closes with a credibility marker and a low-commitment next step.

  4. 14-19s
    The full Important Safety Information scrolls on screen.

    The required safety copy ends the ad.

The offer

A claim that it's the lowest-cost FDA-approved GLP-1, with no price shown. The copy notes that medication and membership terms apply.

Where it sends people

The click lands on Ro's weight-loss quiz entry, which the persona's landing-page ladder puts above a homepage or a basic product page. The page opens with the headline Lose weight on Ro, a photo of Serena Williams labeled as a Ro member, and a card asking which Ro option you're interested in (GLP-1 pill, GLP-1 shot, learn about both, or a provider recommendation), with a banner up top claiming the lowest GLP-1 prices are on Ro. The page's first option, GLP-1 pill, matches the ad exactly, so someone who wants the pill can say so in one tap. That's a good handoff, even though the captured screen doesn't mention the Wegovy pill by name.

The page it sends people to: How Ro turns its Serena Williams ads into a one-question start

Ro's main weight-loss landing page is a quiz entry: Serena Williams, labeled as a Ro member, stands beside a card asking which GLP-1 option you want. It's the destination for 71 Ro ads in the Fluid library, mostly price-led statics, Serena creator videos and pill-versus-pen product stills, nearly all ending on See if you qualify.

How the page is built

  1. 01
    Announcement bar

    A pale yellow strip claims the lowest prices for GLP-1s are on Ro, the page's only answer to 'is this affordable?'

  2. 02
    Headline

    Lose weight on Ro names the category and the brand, so the visitor knows they're in the right place before reading anything else.

  3. 03
    Serena Williams photo

    Serena holds a pen-style product with a Ro member label and a product thumbnail beside her, answering 'is this the thing from the ad?'

  4. 04
    Treatment-format question

    A white card asks which Ro option you're interested in (pill, shot, learn about both, or a provider recommendation), which starts the quiz and sorts visitors by how far along they are.

  5. 05
    Weight-goal question

    After Learn about both, the same card asks how much weight you're looking to lose in ranges plus Not sure yet, keeping the visitor on the page while the quiz continues.

  6. 06
    Footer

    Legal, terms, privacy and consumer health data privacy links sit beside a LegitScript Certified badge, answering 'is this a legitimate pharmacy?' for anyone who scrolls.

The first fixes we would make

  1. Many of the ads sending traffic here lead with price (Half the price, Affordable GLP-1, Same results, more savings), and the page answers with one general claim in the announcement bar. Put a starting price under each format option, using the same number the ad showed, so the person who clicked for the price sees it before they answer.
  2. The format question asks people to choose between a pill and a shot with nothing beside either option. Add a short line under each choice that describes it the way the product-choice ads already do, so someone arriving from a Pill or pen ad can pick without leaving to research.

Read the full breakdown of this page

Three hooks you could test

  • Make the product the whole scene. “Meet the new one. Here's everything that changed.”
  • Sell the outcome. “The routine you wanted, finally in the format you asked for.”
  • Turn the benefit into a picture people get in a second. “One small tablet replaces the part you dreaded.”

What to borrow for your brand

  • Frame a new product as an introduction (Meet the...) so the ad reads as news instead of a pitch.
  • Keep claims to two short cards and put their conditions in fine print on the same frame.
  • Make sure the landing page offers the exact product you just announced as one of its first choices.

Transcript

There's no speech in this video. The on-screen text and music carry the message.
Text on screen
  • Rx only. Stay tuned for Important Safety
  • Information about GLP-1 medications,
  • including Boxed Warning, or go to roco/safety
  • Average weight loss in 1 year is 14% (vs 2.2% with diet and
  • exercise alone). Based on study in non-diabetics with
  • obesityvor overwhight plus a weight-related condition,
  • with diet and exercise. Your results may vary
  • Meet the
  • PROT
  • Wegovy pill
  • Lose 14% of your
  • weight in a yeap ROTECTED
  • The lowest cost
  • FDA-approved GLP-1
  • OTECTED
  • FDA approved
  • TECTED
  • See if you qualify
  • ATED
  • including Boxed Warning, or go to ro.co/safety
  • exercise aiene). Based on study in non-diabetics with
  • obesity or overweight plus a weight-related condition,
  • weight in a yearp ROTECTED
  • PROTECTED
  • Average weight loss in 1 year is 14% (v5 2.2% with diet and
  • TED
  • exercise alene). Based on study in non-diabetics with
  • Important Safety Information, including Boxed Warning
  • Wegovy (semaglutide) may cause possiblethyroid tumors and thyroid cancer.
  • Do not use, it you or any of your famlly have over had a type of thynold cancer
  • callad medullary thyrold carcinoma (MC) or if you have an ondocrine
  • system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
  • Tell your providerif you get a lump or swelting it your neck, hoarseness,
  • trouble swallowing, or shortness of breath. These may be
  • symptoms of thyroid cancer.
  • • Wegovy is a prescription medicine for patients with obesity or with overweight
  • who also have wight-related medical problems, to heip them lose weight. paired
  • with diet and exercise
  • • Wegovy is also used to reduce the risk of major adverse cardiovascular (CV)
  • events in pationts with known heart disease and with other obesity or overweight.

One of 100 Ro ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.